ALCOX — Nicox SA Share News
0.000.00%
Last trade - 00:00- €32.43m
- €28.69m
- €16.77m
Brief: NICOX Q1 Revenue EUR 4.4 Million
Brief: Nicox Amends Debt Agreements For Outstanding Bonds
Brief: Nicox And Kowa Enter Into Agreement For Glaucoma Treatment
Brief: Nicox Is Financed Until June 2024
Brief: Nicox H1 Net Loss Narrows To 6.6 Million Euros
Brief: Nicox Estimates Potential Annual Global Net Sales For NCX 470 Of Over $300 Mln
Brief: Nicox Presented NCX 470 Phase 3 Mont Blanc Adaptive Design Data And Additional Subset Analysis
Brief: Nicox to Presents New Data On Two Nicox’S Assets, Ncx 470 And Ncx 1728, At Arvo 2023
Brief: Nicox Q1 Net Revenue At EUR 0.8 Mln
Europe Research Roundup: Givaudan, National Grid Plc, Teamviewer
Brief: Nicox Submits NDA For ZERVIATE In China For Potential Launch In 2024
Brief: Nicox FY Net Revenue Up At EUR 3.3 Million
Brief: Nicox End-December Cash Position Of 27.7 Million Euros
Brief: Nicox Announces Proposed Move To Euronext Growth Paris
Brief: Nicox Raises 10 Million Euros In Private Placement
Brief: Nicox Outlines Future Development, Partnering Plans For NCX 470 In Glaucoma
Brief: Nicox End-Sept Cash And Cash Equivalents Of EUR 25.6 Million
Brief: Nicox Announces Last Patients Complete Final Visit In Ncx 470 Phase 3 Mont Blanc Glaucoma Trial
Brief: Nicox Group End-June Net Loss At EUR 17.0 Mln